Leading UK health scientists and institutions will provide insight into successful university spinouts, digital health in the NHS, successful Japan-UK research and commercialisation projects, and academic-industry collaborations.
Dr Jorg Taubel and Dr Ulrike Lorch will be in attendance at this one-day event and presenting to the delegation.
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
.avif)
